Grants per year
Personal profile
Research Interests
Dr. Siziopikou's subspecialty focus is on breast tumor markers and molecular diagnostics in breast cancer. Her research interests center around molecular markers of prognostic and predictive significance in breast cancer.
Certifications and Licenses
| Anatomic Pathology |
Training Experience
| 1994 | Residency, Beth Israel Deaconess Medical Center, Boston |
| 1995 | Fellowship, Beth Israel Deaconess Medical Center, Boston |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, Rush Medical Collage
… → 1990
Medicine, MD, Aristotle University of Thessaloniki
… → 1985
Research interests
- Breast Cancer
- Breast Disease
- Cancer Biology
- Pathology
Fingerprint
Dive into the research topics where Kalliopi P Siziopikou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Investigating Environmental Risk Factors for Breast Cancer Using Adductomics
Funk, W. E., Goel, R., Goo, Y. A., Kim, K. A. & Siziopikou, K. P.
National Institute of Environmental Health Sciences
3/11/21 → 12/31/25
Project: Research project
-
Investigating the mechanisms of CD44s splice isoform in breast cancer metastasis
Cheng, C., Cheng, S. & Siziopikou, K. P.
2/4/14 → 5/31/16
Project: Research project
-
Correlation of manual semi-quantitative and automated quantitative Ki-67 proliferative index with OncotypeDX™ recurrence score in invasive breast carcinoma
Finkelman, B. S., Meindl, A., Laboy, C., Griffin, B. B., Narayan, S. P., Brancamp, R., Siziopikou, K. P., Pincus, J. L. & Blanco, L. Z., 2022, In: Breast Disease. 41, 1, p. 55-65 11 p.Research output: Contribution to journal › Article › peer-review
-
Determining PD-L1 Status in Patients with Triple-Negative Breast Cancer: Lessons Learned from IMpassion130
Badve, S. S., Penault-Llorca, F., Reis-Filho, J. S., Deurloo, R., Siziopikou, K. P., D'Arrigo, C. & Viale, G., May 1 2022, In: Journal of the National Cancer Institute. 114, 5, p. 664-675 12 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices
Nauwelaers, I., Laudus, N., Peeters, D., Acs, B., Denkert, C., Michiels, S., Horlings, H., Siziopikou, K. P., Ely, S., Zardavas, D., Mustimbo, R., Bartlett, J., Floris, G., Hartman, J., van Deurzen, C. H. M., Ceusters, D., Dequeker, E. & Salgado, R., Aug 2022, In: Cancers. 14, 15, 3762.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Pathologic evaluation of specimens after neoadjuvant chemotherapy in breast cancer: Current recommendations and challenges
See, S. H. C. & Siziopikou, K. P., Feb 2022, In: Pathology Research and Practice. 230, 153753.Research output: Contribution to journal › Review article › peer-review
-
Clinicopathologic features of unexpectedly HER2 positive breast carcinomas: An institutional experience
LaBoy, C., Siziopikou, K. P., Rosen, L., Blanco, L. Z. & Pincus, J. L., Jun 2021, In: Pathology Research and Practice. 222, 153441.Research output: Contribution to journal › Article › peer-review
2 Scopus citations